1/2 Hola, amb l'estudi IMPACT-T2D volem desenvolupar una estratègia de medicina de precisió per la diabetis tipus 2 que permeti personalitzar les teràpies i minimitzar complicacions greus. Però necessitem incorporar molts pacients residents a Espanya (marc del projecte)!
Congratulations @m_cuencaardura for an outstanding thesis and presentation. I am a proud supervisor. And thank you Patrik Rorsman, @KP_twitt_llo, @lorenzpasquali for coming and for such an interesting discussion
Very glad to share our work published in @CellGenomics! Especially big thanks to @eliasrfos , @anton_gh , @HaaseKerstin and J.Schulte.
Read all about it 🚨📷 1/20
Specific patterns of DNA alterations in #neuroblastoma cells reflect the different aggressiveness of this pediatric #tumor. Researchers from #CharitéBerlin & @MDC_Berlin were able to show this in a recent @CellGenomics study. #Cancer https://t.co/mYsKfBeEDI
Excited to share a Perspective we wrote on ecDNA‘s spatial and genomic mobility and it’s implications for cancer therapy, out today @NatureGenet
Thank you to @SafiaDanovi for the great editorial process !
🔥🔥👇🏻👇🏻
https://t.co/OSZGr3rlHV
Happy to see our latest study "The impact of non-additive genetic associations on age-related complex diseases" published at @NatureComms https://t.co/1cEPUxci6X led by @mguindom which was a pleasure to supervise together with David Torrents. Thread👇
New estimates of the global burden of #cancer in 2020 now published! #Globocan2020. IARC estimates that the cancer burden has risen to 19.3 million new cases & 10.0 million deaths this year https://t.co/wROHL88jf6
⚡️The "Milestones in Cancer" is out and is WONDERFUL. It covers key developments across cancer research in the last 20 years - coordinated by @SafiaDanovi and @SaheliSadanand with input from all cancer editors @NatResCancer
The interactive timeline is🤩
https://t.co/Iuuf0PrYcc
News & Views: An international effort to analyse and sequence nearly 2,700 whole genomes of cancer samples across a range of types of tumour yields insights into the genetic complexity of cancer. This analysis is detailed in six papers published in Nature. https://t.co/NAkk33aR9m
While researchers are racing to unravel the molecular mechanisms behind tumour-promoting bacteria, many cancer researchers are testing whether microbiome-based therapeutics can improve the efficacy or safety of existing anti-cancer interventions. https://t.co/07mG3sacDd
Check out our paper, online today @NatureGenet ! With Richard Koche @sloan_kettering , @eliasrfos from the Torrents lab @BSC_CNS and colleagues @ChariteBerlin@MDC_Berlin, we describe that circular DNA serves as a substrate for oncogenic genome remodelling https://t.co/BV5sQaXA0r